VivoSeq
Other

Hemorrhagic Shock

2

Pipeline Programs↗

5

Active Trials↗

3

Companies Involved↗

Hemorrhagic Shock is an early-stage landscape with 2 programs across 3 companies. The most active players are Eli Lilly, Amring, Innogene Kalbiotech Pte. Ltd. 2 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

6/100

Mech. Concentration

100/100

Completion Rate

88/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

Phase 3A

Amring

1 program

Phase 3I

Innogene Kalbiotech Pte. Ltd

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 32

Tranexamic Acid

Amring

Component Therapy (CT)

Philip Spinella

Approved
No programs

Analysis

Trial Status

16

clinical trials

Completed7 · 44%
Unknown status3 · 19%
Recruiting3 · 19%
Withdrawn1 · 6%
Enrolling by invitation1 · 6%
Not yet recruiting1 · 6%

Clinical Trials

Trial Activity

16 trials

Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock
Recruiting·TTanta University·N/A·NCT06311903·200 enrolled
Whole Blood in Trauma Patients With Hemorrhagic Shock
Recruiting·FFundacion Clinica Valle del Lili·Phase 3·NCT05634109·220 enrolled
Massive Transfusion in Children: a Platform RCT of Whole Blood Compared to Component Therapy and Tranexamic Acid to Placebo in Life-threatening Traumatic Bleeding
Recruiting·—·Phase 3·NCT06070350·1,000 enrolled
Incidence and Predictors of Hemorrhagic Shock in Patients With Long Bone Fractures Presenting to the Emergency Department
Not yet recruiting·SSohag University·N/A·NCT07695129·250 enrolled
Early Norepinephrine in Trauma Patients With Hemorrhagic Shock
Enrolling by invitation·—·Phase 1/2·NCT06977659·40 enrolled
Vasopressin in Traumatic Hemorrhagic Shock Study
Completed·—·Phase 2/3·NCT00379522·64 enrolled
Cold Stored Platelet in Hemorrhagic Shock
Completed·—·Phase 2·NCT04667468·200 enrolled
Phase IIa Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Completed·SSangart·Phase 2·NCT01004198·51 enrolled
Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
Completed·IInnogene Kalbiotech Pte. Ltd·Phase 3·NCT01433276·71 enrolled
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
Completed·UUniversity of Washington·Phase 2·NCT01411852·192 enrolled
Resuscitative Endocrinology: Single-dose Clinical Uses for Estrogen-Traumatic Hemorrhagic Shock (RESCUE - Shock)
Completed·UUniversity of Texas Southwestern Medical Center·Phase 2·NCT00973102·50 enrolled
Phase IIb Study of MP4OX in Traumatic Hemorrhagic Shock Patients
Completed·SSangart·Phase 2·NCT01262196·348 enrolled
Macro and Microcirculatory Effects of the Combination of Norepinephrine and Octreotide for the Treatment of Cirrhotic Patients With Hemorrhagic Shock
Withdrawn·—·N/A·NCT03891849
Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid Balance
Unknown status·SSeoul National University Hospital·N/A·NCT06111261·36 enrolled
Prehospital Kcentra for Hemorrhagic Shock
Unknown status·OOregon Health and Science University·Phase 2·NCT04019015·166 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)